January 15, 2025

FDA to Revoke Red No. 3

Red No. 3 is found in many popular food items, including Pop Tarts, Dole Fruit Packs, Double Bubble Gum, Peeps, and more.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Achalasia: Candida's Role in Cancer Risk

New study links esophageal Candida infection to significant cancer risk increase in achalasia patients.

Conexiant

January 10, 2025

Higher H. pylori Prevalence Seen in Severe Psoriasis

Psoriasis patients show higher Helicobacter pylori infection rates, with potential implications for further research into disease associations.

Conexiant

January 08, 2025

Calcium Cuts Colorectal Cancer Risk by 17%, Large Study Finds

Calcium intake reduces colorectal cancer risk by 17% per 300 mg/day, with dairy sources showing the strongest associations, as revealed in a large-scale study.

Conexiant

January 03, 2025

Surgeon General Issues Advisory on Alcohol, Cancer Link

Of all breast cancer cases in the U.S., 16.4% are directly linked to alcohol consumption.

Conexiant

December 30, 2024

Nine Early Signs Precede Youth MS Diagnosis

Researchers identified a set of symptoms that could be used to predict children who will be diagnosed with multiple sclerosis.

Conexiant

December 23, 2024

Coffee, Tea May Alter Head-Neck Cancer Risk

An updated pooled analysis of 9,548 head and neck cancer cases and 15,783 controls, conducted by the International Head and Neck Cancer Epidemiology Consortium, revealed significant associations.

Conexiant

May 02, 2024

SUC2C Grant Could Facilitate Development of Novel Therapies in Gastroesophageal Cancer

A new collaboration between Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center to enhance gastroesophageal cancer care in patients who do not respond to standard treatment has received a 3-year grant from Stand Up To Cancer (SU2C).

Conexiant